Rankings/Abridge
Abridge logo

Abridge

NativeAI NativePrivateUpdated November 15, 2026

The clinical AI company that did what most healthcare AI companies skip — published their evidence.

Founded
2018
CEO
Shiv Rao
HQ
Pittsburgh, PA, United States
Stage
Private
Revenue
Not disclosed
Total Funding
$1.1B
Employees
501-1000
Flag a data issue
Healthcare ToolsHealthcareAgentic AI
41.4Bluescore
Momentum75.0
Market MapStrong Distribution
Rank change (7d)▼ 13

Executive Summary

Updated Nov 8, 2026

What they do

  • Ambient AI that turns patient-clinician conversations into structured, EHR-ready clinical notes
  • Expanding into prior authorization, coding, nursing documentation and point-of-care decision support
  • Clinician intelligence platform built with Nvidia, including a foundation model for clinical conversations

Why it matters

  • Used by 300+ health systems serving about 250M patients, including Mayo, Duke and Kaiser
  • Won Best in KLAS for ambient AI two years running, ahead of Microsoft's Nuance
  • Very well funded, raising roughly $800M at a $5.3B valuation with a16z and Khosla

Best fit

  • Large Epic-based health systems rolling out ambient documentation to all clinicians
  • Physician-heavy organizations focused on reducing burnout and documentation time
  • Provider groups wanting real-time prior authorization and billable notes from visit conversations

Watch-outs

  • Epic's built-in AI charting and Microsoft Dragon Copilot threaten its standalone value
  • Class actions over patient consent name Abridge customers such as Sutter and Sharp
  • Enterprise-only contracts with custom pricing and no self-serve option for small practices

Products & Offerings

Abridge Ambient Clinical Documentation

Ambient AI that records patient visits and produces structured, specialty-aware notes inside Epic and other EHRs.

EnterpriseEnterpriseFlagship

Clinician Intelligence Platform

Platform announced in June 2026 that coordinates clinical, financial and evidence-based decisions from the clinical conversation, including nursing workflows and real-time claims.

PlatformEnterpriseEmerging2026

Contextual Reasoning Engine

Reasoning layer that reads conversations and chart data to support coding, billable notes and payer requirements.

PlatformEnterpriseCore Platform

Real-Time Prior Authorization (with Availity)

Combines Abridge's reasoning engine with Availity's FHIR-based utilization management APIs to aim for payer decisions during the visit.

EnterpriseEnterpriseEmerging2026

Abridge Assistant

AI assistant for clinicians that answers queries with evidence drawn from partnered medical journals and patient context.

EnterpriseEnterpriseHigh Growth2026

Latest News

Analyst VerdictShortlist

Updated Nov 8, 2026

Abridge is the leading independent ambient documentation vendor, with top KLAS ratings, more than 300 health system deployments and strong funding, so most large health systems should include it in any ambient AI selection. Run it head-to-head against Epic's native AI charting and Microsoft Dragon Copilot, since Mount Sinai chose Microsoft after a bake-off. Before go-live, set clear patient consent workflows and contract terms on data use.

Signal Provenance

Latest observation date and source for each signal category

Signal CategoryLast UpdatedSource
Funding Signals
Last funding round, Funding stage
Nov 15, 2026Cited web research
Hiring Velocity
Headcount, Headcount growth
Nov 15, 2026Research agents (estimate)
Technical Output
Research papers, GitHub activity
Nov 15, 2026Hugging Face Hub + news feed + research agents
News Sentiment
News mentions, News sentiment
Nov 15, 2026Verified news feed
Partnership Signals
Enterprise partnerships, Distribution partners
Nov 15, 2026Research agents (estimate)
Revenue Indicators
ARR estimate, Revenue growth
Nov 15, 2026Research agents (estimate)
Leadership Signals
CEO tenure, Founder-led
Nov 15, 2026Research agents (estimate)
Competitive Position
Category rank, Market share
Nov 15, 2026Research agents (estimate)

Why this Bluescore?

6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology

Abridge's Bluescore of 41.4 rests most on Customer Adoption (6.3, top 15%) and Investment Momentum (6.7, top 21%). Its weakest area is Business Model & Revenue (3.3, 15th percentile).

In plain English

Abridge's Bluescore of 41.4 out of 100 is held back mainly by Business Model & Revenue, at 3.3 of 10 and the 15th percentile among the AI250, and Talent & Research, at 2.5 of 10 and the 18th percentile. Its strongest areas are Customer Adoption, at 6.3 of 10 and the 85th percentile, and Investment Momentum, at 6.7 of 10 and the 79th percentile, which add 8.2 of 13 and 6.7 of 10 points. The biggest lever is Business Model & Revenue, which carries a 21% weight and still has 14.0 points left, so a stronger score there would move the Bluescore more than any other dimension.

Written by AI from the scores below and checked against them; updated nightly.

D1 · Business Model & Revenue (21%)
3.3
+7.0 of 21 pts · 15th pct
D2 · Product Depth (21%)
4.1
+8.6 of 21 pts · 35th pct
D3 · Data & Model Moat (19%)
3.6
+6.9 of 19 pts · 48th pct
D4 · Talent & Research (16%)
2.5
+4.0 of 16 pts · 18th pct
D5 · Customer Adoption (13%)
6.3
+8.2 of 13 pts · Top 15%
D6 · Investment Momentum (10%)
6.7
+6.7 of 10 pts · Top 21%

Risks

Updated Nov 8, 2026

Epic's native AI charting could make standalone ambient scribes less necessary in Epic sites
High
Class actions over recording without consent create legal and reputational exposure for customers
Medium
Microsoft Dragon Copilot competes on bundling and reach to nurses and radiologists
Medium
Newer products like prior authorization, claims and decision support are less proven than the scribe
Medium
High valuation multiple raises pressure on pricing, upselling and long-term contract terms
Low
Feedback